Stock Taper 
AVIDITY PARTNERS MANAGEMENT LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Dianthus Therapeutics, Inc. | DNTH | 2.1M | $205.12M |
 Jade Biosciences, Inc. | JBIO | 1.7M | $37.79M |
 CG Oncology Inc. | CGON | 1.4M | $99.4M |
 Oruka Therapeutics, Inc. | ORKA | 760.42K | $72.37M |
 Immunic, Inc. | IMUX | 669.94K | $10.3M |
 Enliven Therapeutics, Inc. | ELVN | 550K | $27.91M |
 Vir Biotechnology, Inc. | VIR | 519.3K | $5.29M |
 Aktis Oncology, Inc. | AKTS | 484.2K | $15.61M |
 SCYNEXIS, Inc. | SCYX | 260.21K | $1.06M |
 Phathom Pharmaceuticals, Inc. | PHAT | 200K | $2.17M |
 Teva Pharmaceutical Industries Limited | TEVA | 200K | $6.78M |
 Alamar Biosciences, Inc. | ALMR | 110K | $2.98M |
 Tempus AI, Inc. | TEM | 105K | $6.08M |
 DexCom, Inc. | DXCM | 100K | $6.74M |
 Peloton Interactive, Inc. | PTON | 100K | $591K |
 Corvus Pharmaceuticals, Inc. | CRVS | 80K | $1.2M |
 Kailera Therapeutics, Inc. | KLRA | 80K | $1.76M |
 Boston Scientific Corporation | BSX | 80K | $3.41M |
 Repligen Corporation | RGEN | 77.8K | $10.62M |
 Intellia Therapeutics, Inc. | NTLA | 75K | $1.27M |